| Rosanne Deangelis, PA-C | |
|
355 Grand St, Jersey City, NJ 07302-4321 | |
| (201) 915-2505 | |
| Not Available |
| Full Name | Rosanne Deangelis |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 355 Grand St, Jersey City, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225210321 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | 25MP00191800 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rosanne Deangelis, PA-C 355 Grand St, Jersey City, NJ 07302-4321 Ph: () - | Rosanne Deangelis, PA-C 355 Grand St, Jersey City, NJ 07302-4321 Ph: (201) 915-2505 |
News Archive
As part of the American Recovery and Reinvestment Act of 2009, the government is investing billions of dollars to encourage health care providers to use electronic health record systems. Many providers will probably switch from older systems to new systems to qualify for the federal incentives, but whether the upgrade improves patient care and safety has remained an open question.
People with treatment-resistant hypertension successfully reduced their blood pressure by adopting the Dietary Approaches to Stop Hypertension (DASH) eating plan, losing weight, and improving their aerobic fitness by participating in a structured diet and exercise program at a certified cardiac rehabilitation facility, according to new research published today in the American Heart Association's flagship journal Circulation.
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.
Medical or surgical treatment of severe heartburn prevents cancer of the esophagus, a study from Karolinska Institutet with almost one million Nordic patients reveals. The results will be published in the scientific journal JAMA Oncology.
› Verified 2 days ago
Swetal Patel, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 127 Montgomery St, Jersey City, NJ 07302 Phone: 201-431-7200 | |
Rain Thomas, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 377 Jersey Ave Ste 550, Jersey City, NJ 07302 Phone: 703-628-4190 | |
Ajwairia Aslam, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 176 Palisade Ave, Jersey City, NJ 07306 Phone: 201-795-8200 | |
Mirna Bury, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 193 Palisade Ave, Jersey City, NJ 07306 Phone: 201-656-1042 Fax: 201-656-7656 | |
Corey Mckenzie Karpe, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2624 | |
Mrs. Nicole Carrillo, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 377 Jersey Ave Ste 450, Jersey City, NJ 07302 Phone: 201-915-2525 | |
Mrs. Nancy Zaki, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City Medical Center-emergency Dept, Jersey City, NJ 07302 Phone: 201-920-3418 |